Associations between BMI, waist circumference, central obesity and outcomes in type II diabetes mellitus: The ACCORD Trial

Low Wang, 2016, Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations, Circulation, 133, 2459, 10.1161/CIRCULATIONAHA.116.022194 Rawshani, 2018, Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes, N Engl J Med, 379, 633, 10.1056/NEJMoa1800256 Fryar, 2012, Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999–2010, NCHS Data Brief, 103, 1 Control, 2017 Han, 2018, The evidence for an obesity paradox in type 2 diabetes mellitus, Diabetes Metab J, 42, 179, 10.4093/dmj.2018.0055 Abdelaal, 2017, Morbidity and mortality associated with obesity, Ann Transl Med, 5, 161, 10.21037/atm.2017.03.107 Prentice, 2001, Beyond body mass index, Obes Rev, 2, 141, 10.1046/j.1467-789x.2001.00031.x Britton, 2013, Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality, J Am Coll Cardiol, 62, 921, 10.1016/j.jacc.2013.06.027 Yusuf, 2005, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study, Lancet, 366, 1640, 10.1016/S0140-6736(05)67663-5 Czernichow, 2011, Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE, Eur J Cardiovasc Prev Rehabil, 18, 312, 10.1097/HJR.0b013e32833c1aa3 Misra, 2015, Ethnic-specific criteria for classification of body mass index: a perspective for Asian Indians and American Diabetes Association position statement, Diabetes Technol Ther, 17, 667, 10.1089/dia.2015.0007 Winter, 2014, BMI and all-cause mortality in older adults: a meta-analysis, Am J Clin Nutr, 99, 875, 10.3945/ajcn.113.068122 Ismail-Beigi, 2010, Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial, Lancet, 376, 419, 10.1016/S0140-6736(10)60576-4 Group AS, 2007, Action to control cardiovascular risk in diabetes (ACCORD) trial: design and methods, Am J Cardiol, 99, 21i, 10.1016/j.amjcard.2007.03.003 Action to Control Cardiovascular Risk in Diabetes Study G, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, 2545, 10.1056/NEJMoa0802743 https://biolincc.nhlbi.nih.gov/studies/accord/. UDoHaHSNIoHw. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Manual of Procedures. October 24, 2006. Organization WH. Waist circumference and waist-hip ratio. Report of WHO Expert Consultation. 2008. National Heart Lung and Blood Institute, 2000 Group AS, 2016, Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes, Diabetes Care, 39, 701, 10.2337/dc15-2283 Klein, 2007, Am J Clin Nutr, 85, 1197, 10.1093/ajcn/85.5.1197 Wang, 2005, Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men, Am J Clin Nutr, 81, 555, 10.1093/ajcn/81.3.555 1998, Obes Res, 6, 51S, 10.1002/j.1550-8528.1998.tb00690.x Khalili, 2012, Prediction of cardiovascular events with consideration of general and central obesity measures in diabetic adults: results of the 8.4-year follow-up, Metab Syndr Relat Disord, 10, 218, 10.1089/met.2011.0070 OECD, 2017, Obesity among adults, 2015 or nearest year, OECD Obesity Update, 2017 Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med, 347, 305, 10.1056/NEJMoa020245 Kitzman, 2016, The HFpEF obesity phenotype: the elephant in the room, J Am Coll Cardiol, 68, 200, 10.1016/j.jacc.2016.05.019 Savji, 2018, The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF, JACC Heart Fail, 6, 701, 10.1016/j.jchf.2018.05.018 Ardern, 2004, Development of health-related waist circumference thresholds within BMI categories, Obes Res, 12, 1094, 10.1038/oby.2004.137